Revvity insider trading
Health Care · Heavy sellingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 0 Revvity insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $6.0M. 16 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 54 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Anita GonzalesVp And Cao | Sell Plan | 84 | $155.48 | $13K | +1.2% | — |
| Sep 23SEC | Maxwell KrakowiakPlease See Remarks | Sell Plan | 1,631 | $144.53 | $236K | +8.9% | — |
| Sep 18SEC | Tajinder S VohraPlease See Remarks | Sell Plan | 7,330 | $140.88 | $1.0M | +11.7% | — |
| Jul 22SEC | Anita GonzalesPresident | Sell Plan | 85 | $109.48 | $9K | +43.7% | — |
| Apr 22SEC | Anita GonzalesPresident | Sell Plan | 80 | $92.80 | $7K | +69.6% | — |
| Feb 26SEC | Miriame VictorPlease See Remarks | Sell Plan | 1,862 | $97.13 | $181K | +62.0% | — |
| Feb 25SEC | Michelle Mcmurry-heathDirector | Sell | 600 | $97.26 | $58K | +61.8% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 12,186 | $99.55 | $1.2M | +58.1% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 7,885 | $100.63 | $793K | +56.4% | — |
| Feb 6SEC | Joel S GoldbergPlease See Remarks | Sell Plan | 6,424 | $99.47 | $639K | +58.2% | — |
| Feb 6SEC | Joel S GoldbergPlease See Remarks | Sell Plan | 3,544 | $100.50 | $356K | +56.6% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 3,079 | $101.45 | $312K | +55.1% | — |
| Feb 6SEC | Joel S GoldbergPlease See Remarks | Sell Plan | 2,217 | $101.33 | $225K | +55.3% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 1,307 | $99.02 | $129K | +58.9% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 1,068 | $102.52 | $109K | +53.5% | — |
| Feb 6SEC | Joel S GoldbergPlease See Remarks | Sell Plan | 532 | $102.52 | $55K | +53.5% | — |
| Feb 4SEC | Tajinder S VohraPlease See Remarks | Sell Plan | 5,756 | $104.50 | $602K | +50.6% | — |
Insiders at Revvity
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Prahlad R. SinghPlease See Remarks | — | $2.6M | Aug 17, 2026 | — |
| Tajinder S VohraPlease See Remarks | — | $1.6M | Sep 18, 2026 | — |
| Joel S GoldbergPlease See Remarks | — | $1.3M | Aug 18, 2026 | — |
| Maxwell KrakowiakPlease See Remarks | — | $236K | Sep 23, 2026 | — |
| Miriame VictorPlease See Remarks | — | $181K | Feb 26, 2026 | — |
| Michelle Mcmurry-heathDirector | — | $58K | May 11, 2026 | — |
| Anita GonzalesVp And Cao | — | $30K | Oct 2, 2026 | — |
| Alexis P MichasDirector | — | — | Aug 25, 2026 | — |
| Peter BarrettDirector | — | — | May 11, 2026 | — |
| Michel VounatsosDirector | — | — | May 11, 2026 | — |
| Samuel R. ChapinDirector | — | — | May 11, 2026 | — |
| Frank WitneyDirector | — | — | May 11, 2026 | — |
| Michael A KlobucharDirector | — | — | May 11, 2026 | — |
| Sophie V. VandebroekDirector | — | — | May 11, 2026 | — |
| Pascale WitzDirector | — | — | May 11, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about RVTY insiders
Are Revvity insiders buying RVTY stock?
In the past 12 months, 0 insiders reported open-market purchases of RVTY worth $0.
Are Revvity insiders selling RVTY stock?
7 insiders reported sales worth $6.0M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.